When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ALXN - Alexion readies study of Ultomiris in severely ill COVID-19 patients
Alexion Pharmaceuticals Inc.
Alexion Pharmaceuticals (NASDAQ:ALXN) announces plans for a 270-subject Phase 3 clinical trial evaluating Ultomiris (ravulizumab-cwvz) in hospitalized COVID-19 patients with severe pneumonia or acute respiratory distress syndrome.
More news on: Alexion Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,